Autistic disorder with complex IV overactivity: A new mitochondrial syndrome

Journal of Pediatric Neurology

Volumn 9, Issue 4, 2011, Pages 427-434

  Frye, Richard E ^a   Naviaux, Robert K ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism; complex IV; mitochondrial DNA mutation; mitochondrial dysfunction; regression

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; ALANINE; BIOTIN; BIOTINIDASE; CARNITINE ACETYLTRANSFERASE; COPPER; CREATINE KINASE; CYTOCHROME C OXIDASE; FATTY ACID; FOLATE TRANSPORTER; FOLIC ACID; ISOCITRIC ACID; LACTIC ACID; MITOCHONDRIAL DNA; PYRUVIC ACID; TRIACYLGLYCEROL; ZINC;

ARTICLE; AUTISM; BIOCHEMISTRY; BIOGENESIS; BIOTINIDASE DEFICIENCY; CEREBRAL FOLATE DEFICIENCY; CEREBROSPINAL FLUID; CHILD; CHROMOSOME DELETION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE GENOMIC HYBRIDIZATION; COMPLEX IV OVERACTIVITY; CONCENTRATION (PARAMETERS); CONGENITAL HEART MALFORMATION; COPPER DEFICIENCY; CYTOGENETICS; DEVELOPMENTAL DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTROENCEPHALOGRAM; ELECTRON TRANSPORT; EPILEPSY; EPILEPTIC DISCHARGE; FAILURE TO THRIVE; FAMILY HISTORY; FATTY ACID METABOLISM; FEMALE; FOLIC ACID DEFICIENCY; HUMAN; INTELLECTUAL IMPAIRMENT; LUMBAR PUNCTURE; MALE; MICROSCOPY; MUSCLE BIOPSY; RISK FACTOR; SCHIZOPHRENIA; SEIZURE; SKIN BIOPSY; VITAMIN SUPPLEMENTATION; ZINC DEFICIENCY;

EID: 84859782543     PISSN: 13042580     EISSN: 18759041     Source Type: Journal    
DOI: 10.3233/JPN-2011-0507     Document Type: Article

References (49)

1. APA. Diagnostic and Statistical Manual of Mental Disorders (4th ed). Washington: DC, American Psychiatric Association, 1994.
2. Schaefer GB, Mendelsohn NJ. Genetics evaluation for the etiologic diagnosis of autism spectrum disorders. Genet Med 2008; 10: 4-12.
3. Frye RE, Rossignol DA. Mitochondrial dysfunction can con-nect the diverse medical symptoms associated with autism spectrum disorders. Pediatr Res 2011; 69(5 Pt 2): 41R-47R.
4. Rossignol DA, Frye RE. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry 2011.
5. Condie J, Goldstein J, Wainwright MS. Acquired micro-cephaly, regression of milestones, mitochondrial dysfunction, and episodic rigidity in a 46,XY male with a de novo MECP2 gene mutation. J Child Neurol 2010; 25: 633-636.
6. Kriaucionis S, Paterson A, Curtis J, Guy J, Macleod N, Bird A. Gene expression analysis exposes mitochondrial abnormal-ities in a mouse model of Rett syndrome. Mol Cell Biol 2006; 26: 5033-5042. (Pubitemid 43955817)
7. Lys mutation. J Child Neurol 2000; 15: 357-361. (Pubitemid 30418050)
8. Morava E, van den Heuvel L, Hol F et al., Mitochondrial dis-ease criteria: diagnostic applications in children. Neurology 2006; 67: 1823-1826. (Pubitemid 44900760)
9. Wong LJ, Cobb BR, Chen TJ. Molecular analysis of mito-chondrial DNA point mutations by polymerase chain reaction. Methods Mol Biol 2006; 336: 135-143.
10. Wong LJ. Pathogenic mitochondrial DNA mutations in protein-coding genes. Muscle Nerve 2007; 36: 279-293.
11. Gil Borlado MC, Moreno Lastres D, Gonzalez Hoyuela M et al., Impact of the mitochondrial genetic background in com-plex III deficiency. PLoS One 2010; 5. pii: e12801.
12. Merante F, Myint T, Tein I, Benson L, Robinson BH. An additional mitochondrial tRNA(Ile) point mutation (A-to-G at nucleotide 4295) causing hypertrophic cardiomyopathy. Hum Mutat 1996; 8: 216-222. (Pubitemid 26328005)
13. Ohlenbusch A, Wilichowski E, Hanefeld F. Characterization of the mitochondrial genome in childhood multiple sclerosis. I. Optic neuritis and LHON mutations. Neuropediatrics 1998; 29: 175-179. (Pubitemid 28396067)
14. Kösel S, Grasbon-Frodl EM, Mautsch U et al., Novel mu-tations of mitochondrial complex I in pathologically proven Parkinson disease. Neurogenetics 1998; 1: 197-204. (Pubitemid 128684241)
15. Ben-Shachar S, Lanpher B, German JR et al., Microdeletion 15q13.3: a locus with incomplete penetrance for autism, men-tal retardation, and psychiatric disorders. J Med Genet 2009; 46: 382-388.
16. Roe CR, Roe DS. Recent developments in the investigation of inherited metabolic disorders using cultured human cells. Mol Genet Metab 1999; 68: 243-257. (Pubitemid 29501097)
17. Kirby DM, Thorburn DR, Turnbull DM, Taylor RW. Biochem-ical assays of respiratory chain complex activity. Methods Cell Biol 2007; 80: 93-119.
18. Dufour F, Koning E, Nehlig A. Basal levels of metabolic ac-tivity are elevated in Genetic Absence Epilepsy Rats from Strasbourg (GAERS): measurement of regional activity of cy-tochrome oxidase and lactate dehydrogenase by histochem-istry. Exp Neurol 2003; 182: 346-352. (Pubitemid 36937087)
19. Otáhal J, Suchomelová L, Druga R, Kubová H. Changes in cy-tochrome oxidase in the piriform cortex after status epilepticus in adult rats. Epilepsia 2005; 46 Suppl 5: 89-93. (Pubitemid 40962127)
20. Ueki I, Koga Y, Povalko N et al., T. Mitochondrial tRNA gene mutations in patients having mitochondrial disease with lactic acidosis. Mitochondrion 2006; 6: 29-36.
21. Ramelli GP, Gallati S, Weis J, Krähenbühl S, Burgunder JM. Point mutation tRNA(Ser(UCN)) in a child with hearing loss and myoclonus epilepsy. J Child Neurol 2006; 21: 253-255. (Pubitemid 43891155)
22. Virgilio R, Ronchi D, Bordoni A et al., Mitochondrial DNA G8363A mutation in the tRNA Lys gene: clinical, biochemical and pathological study. J Neurol Sci 2009; 281: 85-92.
23. Ezugha H, Goldenthal M, Valencia I, Anderson CE, Legido A, Marks H. 5q14.3 deletion manifesting as mitochondrial disease and autism: case report. J Child Neurol 2010; 25: 1232-1235.
24. Zsurka G, Hampel KG, Nelson I et al., Severe epilepsy as the major symptom of new mutations in the mitochondrial tRNA(Phe) gene. Neurology 2010; 74: 507-512.
25. Tam EW, Feigenbaum A, Addis JB et al., A novel mitochon-drial DNA mutation in COX1 leads to strokes, seizures, and lactic acidosis. Neuropediatrics 2008; 39: 328-334.
26. Mahad DJ, Ziabreva I, Campbell G et al., Mitochondrial changes within axons in multiple sclerosis. Brain 2009; 132(Pt 5): 1161-1174.
27. Lu F, Selak M, O'Connor J et al., Oxidative damage to mi-tochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci 2000; 177: 95-103.
28. Smith KJ, Lassmann H. The role of nitric oxide in multiple sclerosis. Lancet Neurol 2002; 1: 232-241. (Pubitemid 37159185)
29. Wei J, Guo H, Kuo PC. Endotoxin-stimulated nitric oxide production inhibits expression of cytochrome c oxidase in ANA-1 murine macrophages. J Immunol 2002; 168: 4721-4727. (Pubitemid 34441380)
30. Gupta S, Samra D, Agrawal S. Adaptive and Innate Immune Responses in Autism: Rationale for Therapeutic Use of Intra-venous Immunoglobulin. J Clin Immunol 2010.
31. Pardo CA, Vargas DL, Zimmerman AW. Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry 2005; 17: 485-495. (Pubitemid 43086675)
32. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005; 57: 67-81. (Pubitemid 40053317)
33. Sweeten TL, Posey DJ, Shankar S, McDougle CJ. High ni-tric oxide production in autistic disorder: a possible role for interferon-gamma. Biol Psychiatry 2004; 55: 434-437. (Pubitemid 38199995)
34. Söüt S, Zoroǧlu SS, Ozyurt H et al., Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clin Chim Acta 2003; 331: 111-117. (Pubitemid 36412032)
35. Zoroǧlu SS, Yürekli M, Meram I et al., Pathophysiological role of nitric oxide and adrenomedullin in autism. Cell Biochem Funct 2003; 21: 55-60. (Pubitemid 36227827)
36. Kurup RK, Kurup PA. A hypothalamic digoxin-mediated mod-el for autism. Int J Neurosci 2003; 113: 1537-1559.
37. Chauhan A, Essa MM, Muthaiyah B, Brown WT, Chauhan V. Mitochondrial abnormalities in lymphoblasts from autism: P1-01-03. Journal of Neurochemistry 2009; 109 (Suppl. 1): 273 Abstract.
38. James SJ, Rose S, Melnyk S et al., Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism. FASEB J 2009; 23: 2374-2383.
39. Ramaekers VT, Häusler M, Opladen T, Heimann G, Blau N. Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition re-sponding to folinic acid substitution. Neuropediatrics 2002; 33: 301-308. (Pubitemid 36222142)
40. Moretti P, Sahoo T, Hyland K et al., Cerebral folate deficiency with developmental delay, autism, and response to folinic acid. Neurology 2005; 64: 1088-1090. (Pubitemid 40388474)
41. Ramaekers VT, Blau N, Sequeira JM, Nassogne MC, Quadros EV. Folate receptor autoimmunity and cerebral folate defi-ciency in low-functioning autism with neurological deficits. Neuropediatrics 2007; 38: 276-281. (Pubitemid 351737986)
42. Garcia-Cazorla A, Quadros EV, Nascimento A et al., Mito-chondrial diseases associated with cerebral folate deficiency. Neurology 2008; 70: 1360-1362. (Pubitemid 351550342)
43. Ramaekers VT, Hansen SI, Holm J et al., Reduced folate transport to the CNS in female Rett patients. Neurology 2003; 61: 506-515. (Pubitemid 37025368)
44. Lappalainen R, Riikonen RS. Elevated CSF lactate in the Rett syndrome: cause or consequence? Brain Dev 1994; 16: 399-401. (Pubitemid 24349230)
45. Cornford ME, Philippart M, Jacobs B, Scheibel AB, Vinters HV. Neuropathology of Rett syndrome: case report with neu-ronal and mitochondrial abnormalities in the brain. J Child Neurol 1994; 9: 424-431.
46. Tang J, Qi Y, Bao XH, Wu XR. Mutational analysis of mito-chondrial DNA of children with Rett syndrome. Pediatr Neurol 1997; 17: 327-330. (Pubitemid 28018863)
47. Cardaioli E, Dotti MT, Hayek G, Zappella M, Federico A. Studies on mitochondrial pathogenesis of Rett syndrome: ul-trastructural data from skin and muscle biopsies and mutation-al analysis at mtDNA nucleotides 10463 and 2835 J Submi-crosc Cytol Pathol 1999; 31: 301-304. (Pubitemid 129553505)
48. Meng H, Pan H, Qi Y. Role of mitochondrial lesion in patho-genesis of sporadic Rett syndrome. Zhonghua Yi Xue Za Zhi 2001 Jun 10; 81: 662-664 (in Chinese).
49. Naviaux RK. Mitochondrial control of epigenetics. Cancer Biol Ther 2008; 7: 1191-1193.